Work

Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study

Year: 2015

Type: article

Study design: Clinical Trial

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-015-1704-6

Authors: Riccardo Danielli, Roberto Patuzzo, Anna Maria Di Giacomo, Gianfranco Gallino, Andrea Maurichi, Annabella Di Florio, Ornella Cutaia, Andrea Lazzeri, Carolina Fazio, Clelia Miracco, Leonardo Giovannoni, Giuliano Elia, Dario Neri, Michele Maio, Mario Santinami

Institutions: University of Siena, Fondazione IRCCS Istituto Nazionale dei Tumori, Philogen (Italy), Philochem (Switzerland), ETH Zurich

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: American Society of Clinical Oncology

OpenAlex ID: W269359229

FWCI: 6.588

Cites: 38

Cited by: 180

Related to: 10